Cohance Lifesciences to consider Q3 FY26 results on Feb 12, 2026; trading window closed
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has announced that a Meeting of the Board of Directors will be held on Thursday, February 12, 2026. The primary purpose of this m...
Limitations of AI summaries
AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.
Platforms like Prysm provide stock-level and portfolio-level analysis.
Why is Cohance Lifesciences Limited in the news today?
Cohance Lifesciences Limited (COHANCE) is in the news due to the announcement is a routine intimation of a board meeting to approve financial results and a related trading window closure. it does not contain any new financial information or strategic changes.
AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Cohance Lifesciences to consider Q3 FY26 results on Feb 12, 2026; trading window closed
December 29, 2025, 01:55 PM
Top Queries to Ask About Cohance Lifesciences Limited
More Details on This News
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has announced that a Meeting of the Board of Directors will be held on Thursday, February 12, 2026.
The primary purpose of this meeting is to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine-months ending December 31, 2025.
In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's securities will be closed from January 1, 2026, to February 14, 2026, inclusive.
See What Deep Dive Gives You — in Seconds
“what happens when you click
Deep Dive “
“what happens when you click Deep Dive “
Instant AI Summary - “Get clean, noise-free earnings breakdowns.”
PDF Insights - “Download detailed, AI-generated reports.”
Metrics Explained -“Key ratios & trends explained in simple language.”
Want to know if this news pushes your stock up or down?
Just tap
